Company profile for Isotope Technologies Munich

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

ITM Isotope Technologies Munich SE is a privately owned biotechnology and radiopharmaceutical group of companies dedicated to the development, production and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radioisotopes for use in cancer treatment. Since its foundation in 2004, ITM and its subsidiaries have established GMP manufacturing and a robust global supply network of innovative, first-in-cl...
ITM Isotope Technologies Munich SE is a privately owned biotechnology and radiopharmaceutical group of companies dedicated to the development, production and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radioisotopes for use in cancer treatment. Since its foundation in 2004, ITM and its subsidiaries have established GMP manufacturing and a robust global supply network of innovative, first-in-class medical radioisotopes and generator platforms for a new generation of targeted cancer diagnostics and therapies.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Germany
Address
Address
Lichtenbergstrasse 1 85748 Garching / Munich
Telephone
Telephone
+49 89 329 8986 600
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/17/3188899/0/en/ITM-Receives-U-S-FDA-Fast-Track-Designation-for-ITM-94-as-a-Diagnostic-Agent-for-Clear-Cell-Renal-Cell-Carcinoma.html

GLOBENEWSWIRE
17 Nov 2025

https://www.globenewswire.com/news-release/2025/11/13/3187074/0/en/ITM-Announces-FDA-Acceptance-of-New-Drug-Application-NDA-and-PDUFA-Date-for-n-c-a-177Lu-edotreotide-ITM-11-in-Gastroenteropancreatic-Neuroendocrine-Tumors-GEP-NETs.html

GLOBENEWSWIRE
13 Nov 2025

https://www.globenewswire.com/news-release/2025/10/25/3174139/0/en/ITM-Announces-Analyses-from-Phase-3-COMPETE-Data-Showing-Higher-Objective-Response-Rates-with-n-c-a-177Lu-edotreotide-ITM-11-vs-Everolimus-Across-Subgroups-of-Patients-with-GEP-NET.html

GLOBENEWSWIRE
25 Oct 2025

https://www.globenewswire.com/news-release/2025/10/18/3168949/0/en/ITM-Announces-Phase-3-COMPETE-Data-Demonstrating-a-Statistically-Significant-Higher-Objective-Response-Rate-with-n-c-a-177Lu-edotreotide-ITM-11-vs-Everolimus-in-Patients-with-Gastr.html

GLOBENEWSWIRE
18 Oct 2025

https://www.globenewswire.com/news-release/2025/10/17/3168494/0/en/ITM-to-Announce-Phase-3-COMPETE-Trial-Post-Hoc-Subgroup-Analyses-and-Host-Satellite-Symposium-at-NANETS-2025.html

GLOBENEWSWIRE
17 Oct 2025

https://www.globenewswire.com/news-release/2025/10/13/3165357/0/en/ITM-Appoints-Annette-Breunig-as-Chief-People-Officer.html

GLOBENEWSWIRE
13 Oct 2025

ABOUT THIS PAGE

Contact Isotope Technologies Munich and get a quotation

Isotope Technologies Munich is a supplier offers 2 products (APIs, Excipients or Intermediates).

Find a price of Lutetium-177 bulk with DMF offered by Isotope Technologies Munich

Find a price of Gallium bulk offered by Isotope Technologies Munich

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty